Vanguard Capital Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$882K Buy
735
+154
+27% +$157K 0.6% 37
2026
Q1
$534K Buy
581
+6
+1% +$6.08K 0.49% 48
2025
Q4
$618K Sell
575
-110
-16% -$105K 0.49% 41
2025
Q3
$523K Buy
685
+2
+0.3% +$1.49K 0.42% 53
2025
Q2
$532K Buy
683
+128
+23% +$99.5K 0.53% 46
2025
Q1
$458K Sell
555
-10
-2% -$8.32K 0.56% 40
2024
Q4
$436K Hold
565
0.48% 48
2024
Q3
$501K Hold
565
0.53% 45
2024
Q2
$512K Hold
565
0.35% 62
2024
Q1
$440K Buy
565
+20
+4% +$14.2K 0.31% 73
2023
Q4
$318K Buy
545
+50
+10% +$29.2K 0.26% 85
2023
Q3
$266K Buy
+495
New +$255K 0.25% 86
2018
Q3
Sell
-9,396
Closed -$801K 132
2018
Q2
$801K Buy
+9,396
New +$772K 1.06% 29

Other funds holding LLY

Vanguard Capital Wealth Advisors's LLY Position: Q2 2026 in Review

Vanguard Capital Wealth Advisors increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $157K and bringing the position to 735 shares worth $882K. The position accounts for 0.6% of the portfolio, ranked #37.

Vanguard Capital Wealth Advisors first reported a position in LLY in Q2 2018 and has held it in 13 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vanguard Capital Wealth Advisors held 735 shares of Eli Lilly worth $882K as of Q2 2026.
  • Vanguard Capital Wealth Advisors bought 154 Eli Lilly shares in Q2 2026, an estimated $157K.
  • Eli Lilly made up 0.6% of Vanguard Capital Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • Vanguard Capital Wealth Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 13 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.